<?xml version="1.0" encoding="UTF-8"?>
<p id="p0225">The side effects of antiviral drugs cannot be underestimated during the treatment of COVID-19. The 
 <italic>Diagnosis and Treatment Plan of Coronavirus Disease 2019 (Tentative seventh version)</italic> recommends the use of lopinavir and/or ritonavir, both of which are protease inhibitors and should not be used in combination with statins or for patients with coronary heart disease [
 <xref rid="bb0205" ref-type="bibr">41</xref>]. Chloroquine can cause cardiac arrhythmias and even cardiac arrest, the most serious adverse reaction [
 <xref rid="bb0210" ref-type="bibr">42</xref>]. For COVID-19 patients, azithromycin and hydroxychloroquine can increase the risk of different arrhythmias, such as prolonged QT intervals, torsade de pointes and sudden cardiac death [
 <xref rid="bb0215" ref-type="bibr">43</xref>]. In addition, Arbidol is associated with an increase in the heart failure rate when used in combination with drugs such as azithromycin and quinolones [
 <xref rid="bb0220" ref-type="bibr">44</xref>]. Interferons may affect the cardiac conduction system, causing cardiac arrhythmia as well as local myocardial ischemia and cardiomyopathy [
 <xref rid="bb0225" ref-type="bibr">45</xref>].
</p>
